Background: Metastasis of breast carcinoma to the paranasal sinus is rare. There is hardly any accumulated data to guide therapy and counseling.
Introduction
The most common cause of cancer-related death among women worldwide is breast cancer (1) . In Western countries, 6% of the affected women present with metastasized disease at time of diagnosis (2) . Metastases of primary breast carcinoma usually home to bone, lungs, liver or brain. We recently encountered two rare, but comparable cases of breast cancer metastases to the paranasal sinus. After the first case report on this subject by Robin in 1939 (3) about forty similar cases have been described.
However, almost no overall data have yet been collected describing survival rates or treatment options. We therefore performed a systematic review of all cases of breast cancer metastasis to the paranasal sinus in addition to reporting our two cases, aiming to find guidance for therapy and counseling.
The paranasal sinus are a rare but known location for metastases. Previous studies indicate that 8% originates from primary breast cancer. Other, more prevalent metastases in the paranasal sinus are from renal cell carcinoma (40%) and bronchogenic carcinoma (9%); also thyroid gland tumors (8%) and prostate cancer (7%) can metastasize to the paranasal sinus (4) . Clinically, these metastases usually present with unilateral nasal obstruction, epistaxis (especially true for renal cell carcinoma), and symptoms suggesting orbital involvement. Upon imaging, the suspicion of a malignancy is raised when these mostly unilateral processes exhibit destruction of bony boundaries and invasion of surrounding tissues (orbit, anterior skull base, skin, palate, cavernous sinus, etc.).
Case I
A 79-year-old lady presented with right-sided complaints of nasal obstruction, purulent rhinorrhea and post nasal drip. She also experienced headaches located near the right frontal sinus.
She had used several antibiotics without marked effect. Lately, she had noticed a swelling of the nasal dorsum. Her general practitioner suspected an abscess and referred her to our Ear, Nose and Throat department. Infiltration of the skull base and the contralateral ethmoid can clearly be seen, as well as extension to the skin over the zygoma and left cheek.
symptoms were specified in 39 cases. Most common complaints were headache/facial pain, visual complaints, and swelling of the face or eyelids (62, 44, and 28%, respectively). Nasal obstruction and epistaxis were reported in the minority of cases (26 and 8%, respectively).
granulative mass filling the nasal cavity on the left side, from which a biopsy was taken. Computed tomography and magnetic resonance imaging scans described a large mass infiltrating both ethmoidal sinus, the left nasal cavity, the left orbit, the skull base, the cavernous sinus and even the left lateral skull base (Figures 2 and 3) . The facial nerve, however, was not affected by the process. Near the zygoma, infiltration of the skin was observed. Multiple pathologically enlarged cervical lymph nodes were found bilaterally.
The biopsy demonstrated a metastasis of her previous breast carcinoma. The patient had no wish for further diagnostics or treatment, and refused palliative hormonal therapy. She died six months after her first visit to our department.
Materials and methods
Pubmed en Embase medical libraries were queried on August 31st, 2017 for MESH terms 'breast neoplasm' combined with 'paranasal sinus' or 'paranasal neoplasm' (Pubmed), or 'paranasal sinus.mp' and 'breast cancer or breast carcinoma.mp' (Embase).
Titles and abstracts were screened (see below for exclusion criteria). All included articles were hand-searched for additional references. This way, 38 relevant papers were identified containing 40 cases ( Figure 4 and Table 1 
Results
Through a systematic literature search, 40 other cases of breast cancer metastasis to the paranasal sinus were found (Table 1) .
Interestingly, there are two very rare cases in literature regarding breast cancer metastasis to the paranasal sinus in a man (5, 6) . The mean age at the time of discovery of the paranasal metastasis was 60 years, ranging from 34 -83 (n = 39). Presenting signs and Table 1 . Reports of breast cancer metastases to the paranasal sinus.
First Author Year Remarks
Robin (3) 1939 Archilei (13) 1959
No full text available Garrett (14) 1959 Nahum (15) 1963 Bernstein (16) 1966 Sossi (17) 1967 Myers (18) 1968 Jortay (19) 1971 2 cases
Robinson (20) 1973 Barrs (21) 1979 Nelson (22) 1990 Austin (23) 1995 García Triguero (24) 1998
No full text available Pignataro (25) 2001 Monserez (10) 2001 Pitkäranta (26) 2001 Hiromura (27) 2003 Belkheiri (28) 2003
No full text available Asproudis (29) 2004 Marchioni (30) 2004 Busl (31) 2008 Fyrmpas (32) 2008 Huang (33) 2008 2 cases Darouassi (5) 2010 Male patient Cheng (34) 2010 Reimann (35) 2011 Azarpira (36) 2011 Davey (12) 2012 Walker (37) 2013 Atasoy (38) 2013 Johnston (39) 2013 Imre
2013 Pittoni (41) 2014 Leone (42) 2014 Namad (43) 2014 Chafale (44) 2015 Roberts (45) 2015 Agrawal (6) 2016 Male patient
There was a wide variety in times between diagnosis of the primary and the metastasis. In 5 cases the metastasis to the paranasal sinus led to the discovery of the primary tumor. In other cases, several years passed between the treatment of the primary and the discovery of the metastasis. In one case, the metastasis to the paranasal sinus was only discovered during autopsy. Overall, the median time lapse was 33 months (17-72; n = 38). Most cases of paranasal metastasis of breast cancer had metastases in other sites as well; in only 9 cases (21,4%) no other sites were found. In three of these, other distant metastases developed or became apparent within months after first presentation and diagnostic workup. In 9 other cases (21,4%) the presence or absence of other metastases was not described. As such, at least 57% had concurrent metastases elsewhere.
The exact paranasal location of breast cancer metastases varied.
In case of a single site metastasis (n=26), the maxillary (23%) and the ethmoid (23%) sinuses were most often involved, followed by sphenoid (15%) and frontal (5%). In 38% of all cases, the metastasis covered multiple sinus. The more recent reports tend to describe metastasis location in more detail based on availability of imaging modalities such as CT and MRI. As such, coverage of multiple sinus (e.g. maxillary and ethmoid) was related to year of publication.
Expansion into adjacent structures was present in 21 cases (64%; n=33) including orbital invasion, destruction of the anterior skull base, cavernous sinus involvement and induration of the facial skin. In 9 cases, the presence or absence of such expansion was not described; most of these reports were written before 1980.
In general, discovery of breast cancer metastasis to the paranasal sinus has a poor prognosis. The median survival after the first presentation was 6 months (2-13,5; n = 29; 6 cases were lost to follow-up but had a survival of 15 months or more, and were included to determine the median survival). The majority of cases (64%) died within eight months after the diagnosis. None of the patients was reported alive five years after the diagnosis.
Overall, the collected data was too sparse for advanced statisti- and human epidermal growth factor receptor-2 was positive in 4 of 11 cases (36%). As such, receptor status of breast cancer metastasizing to the paranasal sinus was in line with overall expression patterns of primary breast cancers (7) . Moreover, comparison of survival times between different biological subtypes of the primary tumor (data available in 14 cases) showed no differences.
Discussion
Metastasis of primary tumors to the paranasal sinuses is a rare event. In 2001, Prescher and Brors reviewed 169 cases, of which only 8% originated from primary breast cancer (4) . From our own extensive literature search, a total of 40 cases were identified, mostly adding more recent case reports to the ones identified by Prescher and Brors.
The two cases we present in the current paper are generally comparable to those already reported. Some interesting points can be made, however. In case I, the survival of almost five years after the discovery of the paranasal metastasis is the longest yet reported. There are no specific clues explaining this long survival. In case II, there was a concurrent facial nerve palsy on the left side, which has not been reported in other cases. This could not be explained by direct invasion as the metastasis did not come into contact with the facial nerve. Possibly, the facial palsy was a paraneoplastic phenomenon. be aimed at palliation and quality of life. As such, extensive and disfiguring surgical procedures should be avoided. Should there be an indication for surgery, an endoscopic approach is favorable (11) . Suggestions to treat a solitary metastasis as a primary tumor do not find any evidence in the reviewed cases (12) .
Conclusion
To date, forty cases of breast cancer metastasis to the paranasal sinus have been reported. Although we currently report the longest survival (almost five years after diagnosis), prognosis is very poor. Treatment should be aimed at palliation and quality of life.
Obviously, care should be taken when encountering a patient with a history of breast cancer complaining of headaches, facial pain, visual impairment or (unilateral) nasal obstruction.
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Three different hypotheses exist on the exact mechanism of metastasis to the paranasal sinus. The most prevalent hypothesis states that the tumor cells migrate via the vertebral veins and jugular venous system (route of Batson) (8) . Through these valveless veins, metastasic cells could home directly to the paranasal sinus by retrograde flow during moments of increased pressure (as Batson showed during Valsalva manoeuvre) (9) . By others, it is proposed to be a hematogenous pathway, possibly seeding from occult pulmonary (micro)metastases (10) . The third hypothesis is based on symmetrical bilateral ethmoidal metastasis in some cases suggesting leptomeningeal and transcribrosal spread of tumor (10) .
None of the reported cases survived paranasal metastasis of breast carcinoma, not even when this was a solitary metastasis.
The majority of patients died within eight months upon diagnosis. Early diagnosis did not lead to improved survival, nor did any form of treatment result in significantly raised survival times.
None of the patients is reported alive five years later. Furthermore, paranasal metastasis is often a sign of more widespread disease. On the other hand, numbers are low and variation in patient characteristics wide. Still, we feel that treatment should
